Traditional Chinese medicine composite for treating hyperplasia of mammary glands
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of mammary gland hyperplasia and composition, which is applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of mammary gland hyperplasia, such as unsatisfactory curative effect, large side effects, and easy recurrence, and achieves remarkable and reliable curative effect, low cost, and easy preparation Effect
Inactive Publication Date: 2015-05-27
董艳丽
View PDF3 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] In order to overcome the disadvantages of unsatisfactory curative effect, large side effects and easy relapse after drug withdrawal in the prior art in the treatment of hyperplasia of mammary glands by traditional Chin
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0012] A traditional Chinese medicine composition for treating hyperplasia of mammary glands, wherein the raw materials and weight ratio of the medicine are: 20g of Cadida sinensis, 10g of angelica, 15g of white peony root, 15g of poria cocos, 20g of xugufeng, 15g of polygala, 10g of August rhizome, 10g of rose , Morinda officinalis 10g, Epimedium 30g, Campanulaceae 10g, Salvia miltiorrhiza 30g, Rhizoma Chuanxiong 20g, Arthia chinensis 15g, safflower 10g, Leulu 15g, mallow seeds 20g, chrysalis 15g, citrus aurantii 15g, japonica 10g , licorice 6g.
Embodiment 2
[0014] A traditional Chinese medicine composition for treating hyperplasia of mammary glands, wherein the raw materials and weight ratio of the medicine are: 15g Cadida sinensis, 20g Angelica, 5g Paeoniae Alba, 25g Poria cocos, 15g Xugufeng, 20g Polygala, 5g August Zha, 15g rose , Morinda officinalis 5g, Epimedium 40g, Campanulaceae 12g, Salvia miltiorrhiza 35g, Chuanxiong 10g, Arthia chinensis 25g, safflower 12g, leaking reed 20g, mallow seeds 15g, chrysalis 25g, citrus aurantii 5g, japonica 15g , licorice 8g.
Embodiment 3
[0016] A traditional Chinese medicine composition for treating hyperplasia of mammary glands, wherein the raw materials and weight ratio of the medicine are: 25g of cadavericus, 5g of angelica, 20g of white peony root, 10g of poria cocos, 30g of xugufeng, 5g of Polygala, 15g of August Zha, and 20g of rose , Morinda officinalis 12g, Epimedium 25g, Campanulaceae 15g, Salvia miltiorrhiza 10g, Rhizoma Chuanxiong 30g, Arthia chinensis 10g, Safflower 20g, Leuced reed 5g, Mallow seeds 25g, Swamp chrysalis 10g, Fructus aurantii 20g, Yellow bead grass 5g , licorice 15g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a traditional Chinese medicine composite for treating hyperplasia of mammary glands. The traditional Chinese medicine composite comprises the following raw materials in parts by weight: 10-30 parts of stachys sieboldii, 5-20 parts of angelica sinensis, 5-25 parts of radix paeoniae alba, 5-25 parts of poria cocos, 10-30 parts of berba aristolochiae mollissimae, 5-25 parts of polygala root, 5-20 parts of fiveleaf akebia fruits, 5-20 parts of flos rosae rugosae, 5-20 parts of radix morindae officinalis, 10-40 parts of herba epimedii, 5-20 parts of platycodon grandiflorum, 10-40 parts of salvia miltiorrhiza, 10-30 parts of ligusticum wallichii, 5-25 parts of rhizoma pleionis, 5-20 parts of carthamus tinctorius, 5-25 parts of uniflower swisscentaury root, 10-30 parts of chingma abutilon seeds, 5-25 parts of galium aparine, 5-25 parts of fructus aurantii, 5-20 parts of phyllanthus virgatus and 5-15 parts of liquorice. The traditional Chinese medicine composite has efficacies of soothing a liver, resolving depression, invigorating a spleen, replenishing qi, promoting the subsidence of swelling, eliminating stagnation, promoting a blood circulation and dredging collaterals, and has significant curative effect reliability in the aspect of treating the hyperplasia of mammary glands.
Description
technical field [0001] The invention relates to a medicinal preparation of an undetermined structure of a traditional herbal medicine, in particular to a traditional Chinese medicine composition for treating mammary gland hyperplasia. Background technique [0002] Hyperplasia of mammary glands is a common non-inflammatory and non-neoplastic lesion in women. It mainly manifests as hyperplasia of mammary ductal epithelium in varying degrees with dilatation of small and medium-sized ducts, bilateral or unilateral mammary gland masses of different sizes, and the masses are in the form of patches or nodules. Or mixed, it moves when touched, the edge is clear, the skin color does not change, and it is accompanied by pain or pain in the armpit. In severe cases, it can affect normal work and life, or acute mastitis can occur, and what's more, it can cause cancer. At present, there is no specific therapy in western medicine. Although some drugs such as tamoxifen have a certain curat...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more